Max Vásquez

1.5k total citations
16 papers, 1.0k citations indexed

About

Max Vásquez is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Max Vásquez has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Immunology. Recurrent topics in Max Vásquez's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Protein Structure and Dynamics (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Max Vásquez is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Protein Structure and Dynamics (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Max Vásquez collaborates with scholars based in United States. Max Vásquez's co-authors include Harold A. Scheraga, George Némethy, J. Yun Tso, Naoya Tsurushita, Kelly Ong, Paul R. Hinton, Mary G. Johlfs, Meina Tang, Matthew R. Pincus and Stephen Keller and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Biochemistry.

In The Last Decade

Max Vásquez

16 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Vásquez United States 13 685 350 177 133 98 16 1.0k
Markus Marquart Germany 5 932 1.4× 325 0.9× 108 0.6× 300 2.3× 76 0.8× 6 1.2k
Philip W. Payne United States 12 394 0.6× 340 1.0× 230 1.3× 101 0.8× 112 1.1× 19 906
Diana Tello France 16 975 1.4× 576 1.6× 273 1.5× 152 1.1× 73 0.7× 24 1.2k
Janet C. Cheetham United Kingdom 13 861 1.3× 359 1.0× 231 1.3× 265 2.0× 186 1.9× 15 1.4k
Hiroaki Sasakawa Japan 16 734 1.1× 348 1.0× 169 1.0× 83 0.6× 62 0.6× 23 983
Per Jonasson Sweden 21 887 1.3× 372 1.1× 104 0.6× 111 0.8× 165 1.7× 49 1.5k
Martyn C. Botfield United States 22 1.2k 1.8× 260 0.7× 183 1.0× 153 1.2× 210 2.1× 47 2.0k
H. Souchon France 10 556 0.8× 292 0.8× 140 0.8× 137 1.0× 28 0.3× 15 899
Katie Hardman United States 11 564 0.8× 373 1.1× 154 0.9× 119 0.9× 122 1.2× 14 785

Countries citing papers authored by Max Vásquez

Since Specialization
Citations

This map shows the geographic impact of Max Vásquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Vásquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Vásquez more than expected).

Fields of papers citing papers by Max Vásquez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Vásquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Vásquez. The network helps show where Max Vásquez may publish in the future.

Co-authorship network of co-authors of Max Vásquez

This figure shows the co-authorship network connecting the top 25 collaborators of Max Vásquez. A scholar is included among the top collaborators of Max Vásquez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Vásquez. Max Vásquez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tsurushita, Naoya, et al.. (2004). Humanization of a chicken anti-IL-12 monoclonal antibody. Journal of Immunological Methods. 295(1-2). 9–19. 46 indexed citations
2.
Hinton, Paul R., Mary G. Johlfs, Kelly Hanestad, et al.. (2004). Engineered Human IgG Antibodies with Longer Serum Half-lives in Primates. Journal of Biological Chemistry. 279(8). 6213–6216. 209 indexed citations
3.
Link, Brian K., J. Yun Tso, Max Vásquez, et al.. (2001). Humanization and characterization of the anti-HLA-DR antibody 1D10. International Journal of Cancer. 93(4). 556–565. 50 indexed citations
4.
Landolfi, Nicholas F., et al.. (2001). The Integrity of the Ball-and-Socket Joint Between V and C Domains Is Essential for Complete Activity of a Humanized Antibody. The Journal of Immunology. 166(3). 1748–1754. 25 indexed citations
5.
Co, Man Sung, Nicholas F. Landolfi, Jon O. Nagy, et al.. (1999). Properties and pharmacokinetics of two humanized antibodies specific for L-selectin. Immunotechnology. 4(3-4). 253–266. 14 indexed citations
6.
Cole, Michael S., Jia Shi, Margit Homola, et al.. (1999). HuM291, A HUMANIZED ANTI-CD3 ANTIBODY, IS IMMUNOSUPPRESSIVE TO T CELLS WHILE EXHIBITING REDUCED MITOGENICITY IN VITRO1. Transplantation. 68(4). 563–571. 66 indexed citations
7.
Zhou, Zhongxiang, et al.. (1996). Finite-difference solution of the Poisson-Boltzmann equation: Complete elimination of self-energy. Journal of Computational Chemistry. 17(11). 1344–1351. 66 indexed citations
8.
Zhou, Zhongxiang, et al.. (1996). Finite‐difference solution of the Poisson–Boltzmann equation: Complete elimination of self‐energy. Journal of Computational Chemistry. 17(11). 1344–1351. 7 indexed citations
9.
Co, Man Sung, David A. Scheinberg, N M Avdalovic, et al.. (1993). Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody. Molecular Immunology. 30(15). 1361–1367. 55 indexed citations
10.
Sebastiani, Federico, et al.. (1991). Conserved amino acid sequences among plant proteins sorted to protein bodies and plant vacuoles. European Journal of Biochemistry. 199(2). 441–450. 9 indexed citations
11.
Ni, Feng, Yvonne C. Meinwald, Max Vásquez, & Harold A. Scheraga. (1989). High-resolution NMR studies of fibrinogen-like peptides in solution: structure of a thrombin-bound peptide corresponding to residues 7-16 of the A.alpha. chain of human fibrinogen. Biochemistry. 28(7). 3094–3105. 72 indexed citations
12.
Vásquez, Max & Harold A. Scheraga. (1988). Effect of sequence‐specific interactions on the stability of helical conformations in polypeptides. Biopolymers. 27(1). 41–58. 39 indexed citations
13.
Vásquez, Max, Matthew R. Pincus, & Harold A. Scheraga. (1987). Correlation between computed conformational properties of cytochrome c peptides and their antigenicity in a T‐lymphocyte proliferation assay. Biopolymers. 26(3). 373–386. 7 indexed citations
14.
Vásquez, Max, Matthew R. Pincus, & Harold A. Scheraga. (1987). Helix–coil transition theory including long‐range electrostatic interactions: Application to globular proteins. Biopolymers. 26(3). 351–371. 49 indexed citations
15.
Vásquez, Max & Harold A. Scheraga. (1985). Use of buildup and energy‐minimization procedures to compute low‐energy structures of the backbone of enkephalin. Biopolymers. 24(8). 1437–1447. 103 indexed citations
16.
Vásquez, Max, George Némethy, & Harold A. Scheraga. (1983). Computed conformational states of the 20 naturally occurring amino acid residues and of the prototype residue α-aminobutyric acid. Macromolecules. 16(7). 1043–1049. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026